Dernière mise à jour le 17 11 2020
Articles scientifiques
| Année | Référence | Lien vers publication |
| 2020 | Row C et al : Abnormal Bleeding Phenotype in Mild Hemophilia B Patients with the p.Ile112Thr Variation on the Gene for Factor IX | https://pubmed.ncbi.nlm.nih.gov/32996663/ |
| Bouttefroy S et al : Congenital factor XIII deficiency: comprehensive overview of the FranceCoag cohort | https://pubmed.ncbi.nlm.nih.gov/31414482/ | |
| 2019 | Rugeri L et al : Gynecological and obstetric outcome in the French cohort of women with Factor XIII deficiency | https://pubmed.ncbi.nlm.nih.gov/32360976/ |
| Iorio A et al : Establishing the Prevalence and Prevalence at Birth of Hemophilia in Males: A Meta-analytic Approach Using National Registries | https://pubmed.ncbi.nlm.nih.gov/31499529/ | |
| Volkers A et al : Recombinant factor VIII products and inhibitor development in previously untreated patients with severe haemophilia A: Combined analysis of three studies | https://pubmed.ncbi.nlm.nih.gov/31066174/ | |
| 2018 | Doncarli A et al : FranceCoag: A 22-year Prospective Follow-Up of the National French Cohort of Patients With Inherited Bleeding Disorders | https://pubmed.ncbi.nlm.nih.gov/30515664/ |
| Resseguier N et al : Determinants of Adherence and Consequences of the Transition From Adolescence to Adulthood Among Young People With Severe Haemophilia (TRANSHEMO): Study Protocol for a Multicentric French National Observational Cross-Sectional Study | https://pubmed.ncbi.nlm.nih.gov/30049701/ | |
| 2015 | Calvez T et al : Response: Confounding by indication is unlikely to explain the higher inhibitor incidence in boys treated with a recombinant FVIII product | https://pubmed.ncbi.nlm.nih.gov/26069335/ |
| 2014 | Calvez T et al : Recombinant Factor VIII Products and Inhibitor Development in Previously Untreated Boys With Severe Hemophilia A | https://pubmed.ncbi.nlm.nih.gov/25253771/ |
| 2013 | Meunier S et al : Use of clinical practice guidelines on long-term prophylaxis in severe hemophilia in France: a retrospective audit | https://pubmed.ncbi.nlm.nih.gov/23333129/ |
| 2010 | Chambost H et al : Epidemiology of Hereditary Bleeding Disorders: Input of FranceCoag Network | https://pubmed.ncbi.nlm.nih.gov/20654808/ |
| 2007 | Chambost H et al : Implementation of a hepatitis A prevention policy in haemophiliacs: results from the French cohort | https://pubmed.ncbi.nlm.nih.gov/17973847/ |
| 2002 | Gaboulaud V et al : Prevalence of IgG Antibodies to Human Parvovirus B19 in Haemophilia Children Treated With Recombinant Factor (F)VIII Only or With at Least One Plasma-Derived FVIII or FIX Concentrate: Results From the French Haemophilia Cohort | https://pubmed.ncbi.nlm.nih.gov/11841442/ |
| Chambost H et al : What Factors Influence the Age at Diagnosis of Hemophilia? Results of the French Hemophilia Cohort | https://pubmed.ncbi.nlm.nih.gov/12378196/ | |
| 2001 | Calvez T et al : The French Haemophilia Cohort: Rationale and Organization of a Long-Term National Pharmacosurveillance System | https://pubmed.ncbi.nlm.nih.gov/11136385/ |
Nous remercions les auteurs et les éditeurs d'avoir autorisé la publication de ces articles sur webFC. Toute utilisation de ces documents à des fins autres que de recherche personnelle doit être soumise à l'autorisation de l'éditeur.
We acknowledge authors and publishers for permission to publish these articles on webFC. All further use of this material other than for personal research is subject to permission from the Publisher.
Site Login/Mot de passe v01.90